Patient Guides to Clinical Trials

No. Every article on this blog is informational and is grounded in publicly available data from ClinicalTrials.gov, FDA guidance documents, and peer-reviewed research. None of them tell any individual reader whether to join a clinical trial, what trial to consider, or how to interpret their own medical situation. Those are decisions that require a treating physician with full access to the reader's medical history and current treatments. Every article ends with the same recommendation: bring the information to your doctor.

The condition-specific articles ("Cancer Clinical Trials," "Alzheimer's Clinical Trials," etc.) summarize what is registered and recruiting on ClinicalTrials.gov within a particular research area. They are written from the federal registry data and are updated periodically as the trial landscape shifts. The trial roundup articles are useful for orientation, but the live trial pages on this site (and on ClinicalTrials.gov directly) always have the most current status. Treat the blog posts as a primer; verify any specific trial against the live record before contacting a site.

Phase 1 trials test a treatment for the first time in humans, focusing on safety, dosing, and how the body processes the drug. Phase 2 trials evaluate efficacy and side effects in larger groups (typically 100–300 patients). Phase 3 trials confirm efficacy and safety in the largest groups (300–3,000+) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and real-world effectiveness. Some trials register without a phase — common for device, behavioral, surgical, or observational studies. Our "Phases Explained" article walks through each phase in detail.

In most cases, the trial sponsor covers the costs of trial-specific procedures (extra imaging, biopsies, lab draws, the investigational drug or device itself). Standard-of-care portions of the protocol — the medical care you would have received outside the trial — are usually billed to insurance like ordinary care. Some trials offer travel reimbursement or modest stipends. Costs vary widely by trial; the "Do Clinical Trials Pay?" article covers what to ask before you enroll. Always confirm the financial details with the trial site before you start screening.

Eligibility criteria are protocol-specific and often quite narrow. If you do not qualify for one trial, several things may help: ask whether other trials for the same condition have different criteria; check whether expanded access or compassionate use is available for the same investigational treatment; revisit the criteria after a treatment change, since some exclusions are tied to current medications or recent lab values. The "FDA Broadening Eligibility Criteria" article also covers federal guidance pushing sponsors to write less restrictive trial criteria, which is gradually opening trials to patients who would have been excluded a few years ago.